Myocardin functions as an effective inducer of growth arrest and differentiation in human uterine leiomyosarcoma cells

Cancer Research

Volumn 70, Issue 2, 2010, Pages 501-511

  Kimura, Yasunori ^a,b   Morita, Tsuyoshi ^a   Hayashi, Ken'ichiro ^a   Miki, Tsuneharu ^b   Sobue, Kenji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR; MYOCARDIN; P21 ACTIVATED KINASE; SERUM RESPONSE FACTOR;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; UTERUS CANCER;

CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; G1 PHASE; HUMANS; LEIOMYOSARCOMA; MUSCLE, SMOOTH; NUCLEAR PROTEINS; PHENOTYPE; PROMOTER REGIONS, GENETIC; S PHASE; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; UTERINE NEOPLASMS;

EID: 76549124197     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1469     Document Type: Article

References (31)

1. Weiss SW, Goldblum IR. Leiomyosarcoma. In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss's soft tissue tumors. 4th ed. St. Louis: Mosby, Inc.; 2001, p. 727-48.
2. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors:leiomyosarcoma. Cancer Genet Cytogenet 2005;161:1-19.
3. Vardi JR, Tovell HM. Leiomyosarcoma of the uterus: clinicopathologic study. Obstet Gynecol 1980;56:428-34.
4. Zaloudek C, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, editor. Blausteins pathology of the female genital tract. 4th ed. New York (NY): Springer-Verlag; 1994, p. 487-528.
5. Horiuchi A, Nikaido T, Ito K, et al. Reduced expression of calponin h1 in leiomyosarcoma of the uterus. Lab Invest 1998;78:839-46.
6. Amada S, Nakano H, Tsuneyoshi M. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen induces, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 1995;14:134-42.
7. Mittinen M, Lehto VP, Ekblom P, Tasanen A, Virtanen I. Leiomyosarcoma of the mandible: diagnosis as aided by immunohistochemical demonstration of desmin and laminin. J Oral Pathol 1984;13:373-81.
8. Sprogoe-Jakobson S, Holund B. Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus). APMIS 1996;104:705-8.
9. Trzyna W, McHugh M, McCue P, McHugh KM. Molecular determination of the malignant potential of smooth muscle neoplasms. Cancer 1997;80:211-17.
10. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
11. Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999;250:273-83.
12. Wang D, Chang PS, Wang Z, et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001;105:851-62.
13. Yoshida T, Sinha S, Dandre F, et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003;92:856-64.
14. Shore P, Sharrocks AD. The MADS-box family of transcription factors. Eur J Biochem 1995;229:1-13.
15. Pipes GC, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 2006;20:1545-56.
16. Tanaka J, Watanabe T, Nakamura N, Sobue K. Morphological and biochemical analyses of contractile proteins (actin,myosin,caldesmon and tropomyosin) in normal and transformed cells. JCell Sci 1993;104:595-606.
17. Kumer MS, Owens GK. Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol 2003;23:737-47.
18. Wang DZ, Olson EN. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev 2004;14:558-66.
19. Ueki N, Sobue K, Kanda K, Hada T, Higashino K. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci U S A 1987;84:9049-53.
20. Sobue K, Tanaka T, Kanda K, Ashino N, Kakiuchi S. Purification and characterization of cldesmon77: a calmodulin-binding protein that interacts with actin filaments from bovine adrenal medulla. Proc Natl Acad Sci U S A 1985;82:5025-29.
21. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995;75:487-517.
22. Milyavsky M, Shats I, Cholostoy A, et al. Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect. Cancer Cell 2007;11:133-46.
23. Ru-hang T, Xi-Long Z, Thomas EC, et al. Myocardin inhibits cellular proliferation by inhibiting NF-κB(p65)-dependent cell cycle progression. Proc Natl Acad Sci U S A 2008;105:3362-7.
24. Wang Z, Wang D, Hockemeyer D, et al. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-9.
25. Hayashi K, Nakamura S, Nishida W, Sobue K. Bone morphogenetic protein-induced Msx1 and Msx2 inhibit myocardin-dependent smooth muscle gene transcription. Mol Cell Biol 2006;26:9456-70.
26. Morita T, Mayanagi T, Sobue K. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs). Exp Cell Res 2007;313:3432-45.
27. Zilberman A, Dave V, Miano J, Olson EN, Periasamy M. Evolutionarily conserved promoter region containing CArG-like elements is crucial for smooth muscle myosin heavy chain gene expression. Circ Res 1998;82:566-75.
28. Miano JM, Carlson MJ, Spencer JA, Misra RP. Serum response factor-dependent regulation of the smooth muscle calponin gene. J Biol Chem 2000;275:9814-22.
29. Streb JW, Miano JM. AKAP12α, an atypical serum response factor-dependent target gene. J Biol Chem 2005;280:4125-34.
30. Lhonore A, Lamb NJ, Vandromme M, et al. MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration. Mol Biol Cell 2003;14:2151-62.
31. Hirschi KK, Lai L, Belaguli NS, et al. Transforming growth factor-β induction of smooth muscle cell phenotype requires transcriptional and post-transcriptional control of serum response factor. J Biol Chem 2002;277:6287-95.